Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically.
Buchanan MR, Brister SJ. Buchanan MR, et al. Among authors: brister sj. Can J Cardiol. 1995 Mar;11(3):221-7. Can J Cardiol. 1995. PMID: 7889440 Clinical Trial.
Sex-related differences in the pathophysiology of cardiovascular disease: is there a rationale for sex-related treatments?
Buchanan MR, Brister SJ. Buchanan MR, et al. Among authors: brister sj. Can J Cardiol. 2001 Nov;17 Suppl D:7D-13D. Can J Cardiol. 2001. PMID: 11726991 Review. No abstract available.
Revascularization options.
Brister SJ, MacDonald RG. Brister SJ, et al. Can J Cardiol. 1997 Dec;13 Suppl D:11D-22D. Can J Cardiol. 1997. PMID: 9444304 Review. No abstract available.
Results of the BRAT study--a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery.
Buchanan MR, Schwartz L, Bourassa M, Brister SJ, Peniston CM; BRAT Investigators. Buchanan MR, et al. Among authors: brister sj. Can J Cardiol. 2000 Nov;16(11):1385-90. Can J Cardiol. 2000. PMID: 11109035
Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate.
Brister SJ, Buchanan MR. Brister SJ, et al. J Cardiothorac Vasc Anesth. 1995 Jun;9(3):317-21. doi: 10.1016/s1053-0770(05)80329-5. J Cardiothorac Vasc Anesth. 1995. PMID: 7669967 No abstract available.
Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
Brister SJ, Ofosu FA, Buchanan MR. Brister SJ, et al. Thromb Haemost. 1993 Aug 2;70(2):259-62. Thromb Haemost. 1993. PMID: 8236131
Cardiopulmonary bypass pumps and thrombin generation: what goes around comes around.
Brister SJ, Pelletier A, Fedorshyn J, Puchalski S, Buchanan MR. Brister SJ, et al. ASAIO J. 1998 Nov-Dec;44(6):794-8. doi: 10.1097/00002480-199811000-00006. ASAIO J. 1998. PMID: 9831087
Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR, Brister SJ. Buchanan MR, et al. Among authors: brister sj. Thromb Res. 2000 Sep 15;99(6):603-12. doi: 10.1016/s0049-3848(00)00276-0. Thromb Res. 2000. PMID: 10974347
Regulation of endothelial cell and platelet receptor-ligand binding by the 12- and 15-lipoxygenase monohydroxides, 12-, 15-HETE and 13-HODE.
Buchanan MR, Horsewood P, Brister SJ. Buchanan MR, et al. Among authors: brister sj. Prostaglandins Leukot Essent Fatty Acids. 1998 May;58(5):339-46. doi: 10.1016/s0952-3278(98)90069-2. Prostaglandins Leukot Essent Fatty Acids. 1998. PMID: 9690711
A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.
Buchanan MR, Brister SJ. Buchanan MR, et al. Among authors: brister sj. Wien Klin Wochenschr. 1999 Feb 12;111(3):81-9. Wien Klin Wochenschr. 1999. PMID: 10093889 Review.
44 results
Jump to page
Feedback